|
Antimicrobial-resistant infections have the potential to increase morbidity and mortality, prolong hospital stays, cause disease-related complications, and increase treatment-related costs. New strategies, federal reforms, and pharmacologic approaches to prevent and treat antibiotic-resistant infectious diseases are investigated in this CME-certified program.
|